2BBBullish & Bearish
Amneal Pharmaceuticals, Inc. (AMRX) trades on NASDAQ. It operates in the Health Care sector, Drug Manufacturers - Specialty & Generic industry. Its current 2BB score is 53 out of 100.
Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products. The company is headquartered in Bridgewater, New Jersey, and is one of the largest manufacturers of generic drugs in the United States.
Amneal Pharmaceuticals, Inc.’s current 2BB score is 53 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 62 | High |
| Momentum | 48 | Stable |
| Financial strength | 51 | Normal |
| Quality | 100 | Very Strong |
| Risk | 44 | Moderate |
| CEO | Chintu Patel | Chirag Patel |
| Headquarters | Bridgewater, New Jersey, United States |
| Founded | 2002 |
| Employees | 8.7K |
| P/E ratio | 37.58 |
| 52-week range | $9.28 – $19.26 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-25 | — | 0.2372 | — | $843.54M |
| 2026-10-28 | — | 0.2295 | — | $824.44M |
| 2026-07-30 | — | 0.2259 | — | $783.57M |
| 2026-04-22 | 0.27 | 0.1734 | $722.52M | $729.58M |